Detalhe da pesquisa
1.
Effect of once-weekly dulaglutide on glycated haemoglobin (HbA1c) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1c.
Diabetes Obes Metab
; 20(2): 409-418, 2018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-28817231
2.
Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 1 diabetes: A randomized, open-label clinical trial.
Diabetes Obes Metab
; 20(9): 2220-2228, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-29766635
3.
Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 2 diabetes: A randomized, open-label clinical trial.
Diabetes Obes Metab
; 20(9): 2229-2237, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-29761615
4.
Variability in and predictors of glycaemic responses after 24 weeks of treatment with exenatide twice daily and exenatide once weekly.
Diabetes Obes Metab
; 19(12): 1793-1797, 2017 12.
Artigo
Inglês
| MEDLINE | ID: mdl-28573708
5.
Linagliptin as add-on to empagliflozin and metformin in patients with type 2 diabetes: Two 24-week randomized, double-blind, double-dummy, parallel-group trials.
Diabetes Obes Metab
; 19(2): 266-274, 2017 02.
Artigo
Inglês
| MEDLINE | ID: mdl-27762093
6.
Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study.
Cardiovasc Diabetol
; 14: 116, 2015 Sep 04.
Artigo
Inglês
| MEDLINE | ID: mdl-26338040
7.
2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial.
Lancet
; 380(9840): 475-83, 2012 Aug 04.
Artigo
Inglês
| MEDLINE | ID: mdl-22748821
8.
Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial.
Lancet
; 379(9833): 2270-8, 2012 Jun 16.
Artigo
Inglês
| MEDLINE | ID: mdl-22683137
9.
Low performance in attention testing is associated with reduced grey matter density of the left inferior frontal gyrus in euthyroid patients with Hashimoto's thyroiditis.
Brain Behav Immun
; 27(1): 33-7, 2013 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-23010451
10.
Saxagliptin vs. glipizide as add-on therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin alone: long-term (52-week) extension of a 52-week randomised controlled trial.
Int J Clin Pract
; 67(4): 307-16, 2013 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-23638466
11.
[Gastrointestinal hormones: their increasing pharmacotherapeutic relevance in metabolic diseases]. / Gastrointestinale Hormone zunehmende arzneitherapeutische Bedeutung bei Stoffwechselerkrankungen.
Inn Med (Heidelb)
; 64(2): 205-210, 2023 Feb.
Artigo
Alemão
| MEDLINE | ID: mdl-36598526
12.
The development of the Tuebingen Cushing's disease quality of life inventory (Tuebingen CD-25). Part I: construction and psychometric properties.
Clin Endocrinol (Oxf)
; 76(6): 851-60, 2012 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-21801193
13.
The development of the Tuebingen Cushing's disease quality of life inventory (Tuebingen CD-25). Part II: normative data from 1784 healthy people.
Clin Endocrinol (Oxf)
; 76(6): 861-7, 2012 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-22066792
14.
Thyroid peroxidase antibody positivity is associated with symptomatic distress in patients with Hashimoto's thyroiditis.
Brain Behav Immun
; 26(4): 559-63, 2012 May.
Artigo
Inglês
| MEDLINE | ID: mdl-22285302
15.
Anorexigenic effects of GLP-1 and its analogues.
Handb Exp Pharmacol
; (209): 185-207, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-22249815
16.
Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity.
Front Endocrinol (Lausanne)
; 13: 1004044, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-36313764
17.
The incretin/glucagon system as a target for pharmacotherapy of obesity.
Obes Rev
; 23(2): e13372, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34713962
18.
Considering Insulin Secretory Capacity as Measured by a Fasting C-Peptide/Glucose Ratio in Selecting Glucose-Lowering Medications.
Exp Clin Endocrinol Diabetes
; 130(3): 200-204, 2022 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-32947641
19.
Obesity and Impaired Metabolic Health Increase Risk of COVID-19-Related Mortality in Young and Middle-Aged Adults to the Level Observed in Older People: The LEOSS Registry.
Front Med (Lausanne)
; 9: 875430, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-35646955
20.
Deteriorated executive functions in patients with successful surgery for pituitary adenomas compared with other chronically ill patients.
J Int Neuropsychol Soc
; 17(2): 369-75, 2011 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-21205414